Herbert Virgin - Aug 9, 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
EVP, Research & CSO
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Aug 9, 2022
Transactions value $
$189,658
Form type
4
Date filed
8/10/2022, 04:50 PM
Previous filing
Mar 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Options Exercise $107K +70.2K +38.06% $1.53* 255K Aug 9, 2022 Direct
transaction VIR Common Stock Options Exercise $82.3K +7.92K +3.11% $10.40 263K Aug 9, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Options Exercise $0 -70.2K -33.34% $0.00 140K Aug 9, 2022 Common Stock 70.2K $1.53 Direct F1
transaction VIR Stock Option (Right to Buy) Options Exercise $0 -7.92K -5.94% $0.00 125K Aug 9, 2022 Common Stock 7.92K $10.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested and exercisable.
F2 1/4 of the shares subject to the stock option vested and become exercisable on July 12, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter.